Revolutionizing Clinical Trials: The Launch of Veeva Study Builder Agent

Veeva Study Builder Agent: Transforming Clinical Study Configurations

Veeva Systems, a leader in cloud-based technology solutions for the life sciences industry, has recently unveiled its innovative Veeva Study Builder Agent. This AI-driven tool is designed to streamline the process of configuring clinical studies, enabling teams to set up their studies in as little as one day.

What is Veeva Study Builder Agent?

The Veeva Study Builder Agent utilizes existing organizational standards and leverages the Unified Study Definitions Model (USDM) from the Clinical Data Interchange Standards Consortium (CDISC). This allows the agent to create Electronic Data Capture (EDC) forms and Data Quality Systems (DQS) configurations more efficiently and consistently. By adhering to well-established processes, the results are not only faster but also minimize discrepancies and enhance readiness for audits.

Efficiency Through Automation

One of the standout features of the Veeva Study Builder Agent is its ability to automate critical tasks involved in study setup. This includes the generation of test data, validation rules, and the configuration of visits and EDC forms. The automation of these processes not only reduces the time taken to prepare studies but also decreases the likelihood of human error, improving overall data integrity throughout the trial phases.

Drew Garty, the Chief Technology Officer at Veeva Clinical Data, emphasized the agent's impact, stating, "Veeva Study Builder Agent will enable faster creation of high-quality studies. We are dedicated to innovations that simplify, standardize, and connect clinical trials, and this agent is a significant step toward realizing that vision."

Availability and Implementation

The Veeva Study Builder Agent will be available to early adopters starting December 2026. Notably, it is integrated within the EDC and does not require an additional license, simplifying accessibility for clients.

In terms of implementation, the agent is provided as a plug-in for Claude Cowork and can be installed directly from a GitHub repository managed by Veeva. This seamless integration ensures that users can easily implement the tool within their existing frameworks without extensive downtime or resource reallocation.

Upcoming Events

For those interested in learning more about Veeva’s offerings, the company will showcase its clinical data solutions, including the EDC, DQS, and eCOA, at the Veeva RD and Quality Summit in Boston on October 20-21, 2026. This event, exclusively for life sciences professionals, presents an excellent opportunity for industry experts to engage and explore the cutting-edge advancements Veeva has to offer.

About Veeva Systems

Veeva Systems stands as a benchmark in providing cloud solutions for the life sciences sector, offering applications, agents, services, and consultancy to over 1,500 clients, from large pharmaceutical companies to emerging biotechnology firms. As a Public Benefit Corporation, Veeva is dedicated to balancing stakeholder interests and delivering superior product excellence and innovation.

Through initiatives like the Veeva Study Builder Agent, Veeva reinforces its commitment to advancing clinical research and providing actionable solutions to enhance trial efficiency. For more information about their offerings, visit veeva.com.

Conclusion

The introduction of the Veeva Study Builder Agent marks a transformative advancement in the realm of clinical trials. By significantly enhancing the speed and accuracy of study configurations, Veeva continues to lead the charge in improving how clinical trials are conducted, ensuring that breakthroughs in medical research are achieved faster and more efficiently than ever before.